Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ilypsa Inc.

Division of Amgen Inc.
www.ilypsa.com

Latest From Ilypsa Inc.

Relypsa’s Potassium-Lowering Drug Clears FDA, But Dosing Warning Could Impact Use

Boxed warning says other oral drugs should be taken at least 6 hours before or after; Veltassa to launch in January with support from Sanofi’s sales force.

BioPharmaceutical United States

Financings Of The Fortnight: Cutting-Edge Biomedical Technology Drawing Big Investments

Juno Therapeutics and Moderna Therapeutics both leveraged promising technologies to bring home venture rounds of more than $100 million in recent weeks. Plus news on recent financings by Argos Therapeutics, Xencor, Sitari and 5am Ventures.

Business Strategies

Financings Of The Fortnight: Haircuts And Postponements Increasing As IPO Burst Slows Down

The IPO boom of 2013 is showing signs of slowing, while class of 2012 companies are seeing stock prices decline. Plus news on recent financings by Relypsa, Synta Pharmaceuticals, ArGEN-X and Karyopharm Therapeutics.

Business Strategies

Karyopharm Scores $48M Series B To Advance Early Cancer Compounds

The Massachusetts biotech has remained well-funded despite shying away from venture capital investors and seeking funds from private investors.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Renal System
  • Alias(es)
  • Symyx Therapeutics Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Amgen Inc.
  • Senior Management
  • Jay P Shepard, Pres. & CEO
    Gerrit Klaerner, PhD, SVP, CBO
    Detlef Albrecht, MD, SVP, R&D & CMO
  • Contact Info
  • Ilypsa Inc.
    Phone: (408) 200-9500
    5301 Patrick Henry Dr.
    Santa Clara, CA 95054
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register